ijms-logo

Journal Browser

Journal Browser

Precision Medicine for Oral Diseases and Cancers

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 1728

Special Issue Editors


E-Mail Website
Guest Editor
Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Interests: cancer; laboratory medicine; personalized medicine; diagnostic; microbiota

E-Mail Website
Guest Editor
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy
Interests: scientific research activity in dentistry; stem cells and regenerative medicine; oral microbiology; public health and preventive medicine; biotechnology; translational medicine and dental hygiene
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Precision medicine has emerged as a powerful model that focuses on how biomolecular factors can influence individual responses to different medications/therapies affecting drug efficacy, side effects and adverse events related to therapy. The long-term goal of the research being conducted is the identification of responders and non-responders to therapy and, thus, the avoidance of adverse events and the optimization of drug/therapeutic doses. The study of the molecular and cellular mechanisms that regulate complex systems requires an intense interaction between basic and applied research. Translational medicine combines biomedical skills and advancements in basic research with clinical reality.

Suitable topics include, but are not limited to, the following: translational research, precision/personalized medicine stem cells, bioscaffolds, biomedical devices, health informatics, bioinformatics, biotechnology, biomechanics, computational mechanobiology, microbiota, and the role of oral health and disease on contributing to general health and systemic conditions. The main focus is on novel developments and applications in precision medicine and relevant themes. We especially encourage the submission of interdisciplinary work research and welcome submissions of original research papers using different study designs and critical and relevant reviews.

Prof. Dr. Marina Di Domenico
Dr. Andrea Ballini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • laboratory medicine
  • personalized medicine
  • diagnostic
  • machine learning
  • precision medicine
  • stem cells
  • oral diseases
  • clinical biochemistry
  • translational medicine
  • geometry optimization of biomaterials
  • cell adhesion
  • computational mechanobiology
  • bioengineering
  • bioscaffolds
  • systemic diseases
  • general health
  • quality of life
  • microbiota

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

12 pages, 3369 KiB  
Article
The Dynamics of OXA-23 β-Lactamase from Acinetobacter baumannii
by Roberto Arrigoni, Andrea Ballini, Luigi Santacroce and Luigi Leonardo Palese
Int. J. Mol. Sci. 2023, 24(24), 17527; https://doi.org/10.3390/ijms242417527 - 15 Dec 2023
Cited by 1 | Viewed by 964
Abstract
Antibiotic resistance is a pressing topic, which also affects β-lactam antibiotic molecules. Until a few years ago, it was considered no more than an interesting species from an academic point of view, Acinetobacter baumanii is today one of the most serious threats [...] Read more.
Antibiotic resistance is a pressing topic, which also affects β-lactam antibiotic molecules. Until a few years ago, it was considered no more than an interesting species from an academic point of view, Acinetobacter baumanii is today one of the most serious threats to public health, so much so that it has been declared one of the species for which the search for new antibiotics, or new ways to avoid its resistance, is an absolute priority according to WHO. Although there are several molecular mechanisms that are responsible for the extreme resistance of A. baumanii to antibiotics, a class D β-lactamase is the main cause for the clinical concern of this bacterial species. In this work, we analyzed the A. baumanii OXA-23 protein via molecular dynamics. The results obtained show that this protein is able to assume different conformations, especially in some regions around the active site. Part of the OXA-23 protein has considerable conformational motility, while the rest is less mobile. The importance of these observations for understanding the functioning mechanism of the enzyme as well as for designing new effective molecules for the treatment of A. baumanii is discussed. Full article
(This article belongs to the Special Issue Precision Medicine for Oral Diseases and Cancers)
Show Figures

Figure 1

Other

Jump to: Research

13 pages, 13195 KiB  
Case Report
Treatment of Odontogenic Maxillary Sinusitis with the Use of Growth Factors in Advanced Platelet-Rich Fibrin for Immediate Closure of Oro-Antral Communication: A Case Report
by Paulina Adamska, Dorota Pylińska-Dąbrowska, Marcin Stasiak, Magdalena Kaczoruk-Wieremczuk, Ewa Kozłowska, Adam Zedler and Michał Studniarek
Int. J. Mol. Sci. 2024, 25(8), 4339; https://doi.org/10.3390/ijms25084339 - 14 Apr 2024
Viewed by 517
Abstract
Chronic odontogenic maxillary sinusitis (COMS), a prolonged inflammation of the maxillary sinus lasting over 12 weeks, is often a result of periapical lesions, marginal periodontitis, and complications like oro-antral communication (OAC) and fistula (OAF). OAC, commonly emerging post-teeth extraction in the lateral maxilla, [...] Read more.
Chronic odontogenic maxillary sinusitis (COMS), a prolonged inflammation of the maxillary sinus lasting over 12 weeks, is often a result of periapical lesions, marginal periodontitis, and complications like oro-antral communication (OAC) and fistula (OAF). OAC, commonly emerging post-teeth extraction in the lateral maxilla, lacks documented treatments using advanced platelet-rich fibrin (A-PRF). This study evaluates A-PRF’s efficacy in treating COMS and immediately sealing extensive OAC. A case of a 28-year-old male with COMS linked to a periapical lesion and supernumerary molars is presented. Treatment involved extracting specific teeth while preserving adjacent ones and using A-PRF for immediate OAC closure. A-PRF, enriched with growth factors, was pivotal in healing, showcasing enhanced tissue regeneration, pain reduction, and faster recovery. The findings suggest A-PRF as an effective adjunct in treating extensive OAC and COMS, proposing its inclusion in standard treatment protocols. This study underscores A-PRF’s potential in improving outcomes for patients with COMS and related complications. Full article
(This article belongs to the Special Issue Precision Medicine for Oral Diseases and Cancers)
Show Figures

Figure 1

Back to TopTop